Bioanalysis & Characterisation for Drug Development

Accurate, compliant bioanalytical services for startups, biotech, and pharma.
Schedule a Call
hVIVO_Lab_Services_Cell_Culture_Lab

Ensuring Accurate Bioanalytical Insights for Clinical Success

Precise bioanalysis and compound characterisation are essential for successful drug development. From early discovery to clinical trials, we deliver accurate, regulatory-compliant data that supports decision-making and accelerates timelines.

 

What is Bioanalysis?

Bioanalysis involves the quantitative measurement of drugs, metabolites, and biomarkers in biological matrices. It underpins pharmacokinetic and toxicology studies, ensuring safety and efficacy profiles are well understood. 

 

Characterisation of Compounds

Characterisation confirms the identity, purity, and stability of your compound. For biologics, this includes structural analysis and functional assays; for small molecules, impurity profiling and stability testing are key, for large molecules binding and target testing.

 

Our Expertise

  • PK and Biodistribution for drug concentration at target site
  • Immunoassays for biomarker detection
  • Stability and degradation studies
  • Impurity profiling and structural characterisation
  • For large molecule bioanalysis, PK, ADA, Nab in addition to biomarker detection
hVIVO_Lab_Services_ELISpot-1

Benefits for Startups, Biotech, and Pharma

Workshop_dark_green

Startups

Rapid, cost-effective solutions for early-stage development

Molecular Biology_black

Biotech

Scalable services for complex molecules
Specimens_dark_green

Pharma

GLP-compliant workflows for global regulatory submissions

Working with hVIVO for Bioanalysis Characterisation

Samples Annual Processing Capacity_bright_green

Sample Preparation

Laboratories_bright_green

Analytical Testing

BLS2 & BLS3_bright_green

Data Interpretation

Factsheet_bright_green

Reporting & Compliance

Our Pathogens

Virus

  • Adenovirus (Including Type 1, Type 2 and Type 3)

  • Adenovirus F40/41

  • Astrovirus

  • Chikungunya

  • Cytomegalovirus (CMV)

  • Dengue (serotypes 1,2,3 and 4)

  • Ebola

  • Enterovirus (EV)

  • Equine Encephalitis (WEEV & VEEV)

  • HCoV- Coronavirus HKU1

  • HCoV- Coronavirus NL63

  • HCoV- Coronavirus OC43

  • HCoV-Coronavirus 229E

  • Herpes simplex virus 1 (HSV-1)Herpes simplex virus 2 (HSV-2)

  • Human herpesvirus 6 (HHV-6)

  • Human Metapneumovirus (hMPV)

  • Human parechovirus (HPeV)

  • Human Rhinovirus (HRV-16)

  • Human Rhinovirus/Enterovirus

  • Influenza - A/Brisbane/10/2007(H3N2)

  • Influenza - A/California/123/2022 (H3N2)

  • Influenza - A/California/45/2023 (H3N2)

  • Influenza - A/Croatia/10136RV/2023 (H3N2)

  • Influenza - A/District of Columbia/27/2023 (H3N2)

  • Influenza - A/Georgia/12/2022 (H1N1)

  • Influenza - A/Massachusetts/18/2022 (H3N2)

  • Influenza - A/New Caledonia/20/99 (H1N1 )

  • Influenza - A/West Virginia/30/2022(H1N1)

  • Influenza - A/Wisconsin/67/2022 (H1N1)

  • Influenza - B/Austria/1359417/2021

  • Influenza - B/Connecticut/01/2021

  • Influenza - B/Phuket/3073/2013

  • Lassa

  • Marburg

  • MERS-CoV

  • Nipah

  • Norovirus GI/GII

  • Parainfluenza virus 1

  • Parainfluenza virus 2

  • Parainfluenza virus 3

  • Parainfluenza virus 4

  • Rabies

  • Respiratory Syncytial Virus (RSV A)

  • Respiratory Syncytial Virus (RSV B)

  • Rotavirus A

  • Sapovirus (I, II, IV, and V)

  • SARS-CoV-1

  • SARS-CoV-2

  • Semliki Forest

  • Varicella zoster virus (VZV)

  • West Nile

  • Yellow Fever

  • Zika

FAQ

Get in touch with us

We support a wide range of analytes and therapeutic modalities, including small molecules, biologics, peptides, vaccines, and biomarkers. Our capabilities cover method development, validation, and sample analysis using fit‑for‑purpose assays to support discovery through late‑phase clinical development.

All bioanalytical and characterisation work is performed within controlled laboratory environments, following relevant regulatory guidelines such as GxP where required. We apply robust quality controls, fully documented workflows, and experienced scientific oversight to ensure data integrity, traceability, and reproducibility throughout each study.
Yes. Our bioanalysis and characterisation services are designed to integrate seamlessly with our wider laboratory and clinical capabilities. This enables streamlined sample handling, faster data turnaround, and better cross‑study insight, helping sponsors reduce timelines and complexity across their development programmes.

Bring your challenge model to life with expert scientific support

Enquire now

Contact Us